Current
$22.2B
5-Year Average
$10.7B
All-Time High
$44.7B
All-Time Low
$11.6M
Market cap daily chart for Insmed (INSM)
Aug 2, 2021 – Jul 29, 2026 · 1,253 trading days
Market Cap growth chart for Insmed (INSM) from 2017 to 2026
Latest: -40.2%
Market Cap history table for Insmed (INSM) from 2000 to 2026
| 2026 | $22.2B | -40.2% | -$15B | ||
| 2025 | $37.2B | +228.3% | +$25.9B | ||
| 2024 | $11.3B | +160.2% | +$6.97B | ||
| 2023 | $4.35B | +77.0% | +$1.89B | ||
| 2022 | $2.46B | -19.5% | -$596M | ||
| 2021 | $3.05B | -6.0% | -$195M | ||
| 2020 | $3.25B | +60.9% | +$1.23B | ||
| 2019 | $2.02B | +100.2% | +$1.01B | ||
| 2018 | $1.01B | -51.4% | -$1.07B | ||
| 2017 | $2.08B | +153.5% | +$1.26B | ||
| 2016 | $819M | -23.1% | -$245M | ||
| 2015 | $1.06B | +59.6% | +$398M | ||
| 2014 | $667M | +12.1% | +$72M | ||
| 2013 | $595M | +234.9% | +$417M | ||
| 2012 | $178M | +149.4% | +$106M | ||
| 2011 | $71.2M | -14.8% | -$12.4M | ||
| 2010 | $83.6M | -14.7% | -$14.4M | ||
| 2009 | $98M | +71.6% | +$40.9M | ||
| 2008 | $57.1M | -39.7% | -$37.5M | ||
| 2007 | $94.6M | +12.8% | +$10.7M | ||
| 2006 | $83.9M | -12.6% | -$12.1M | ||
| 2005 | $96M | +11.5% | +$9.91M | ||
| 2004 | $86.1M | -18.6% | -$19.6M | ||
| 2003 | $106M | +626.7% | +$91.2M | ||
| 2002 | $14.5M | -88.4% | -$111M | ||
| 2001 | $126M | +97.6% | +$62M | ||
| 2000 | $63.5M | — | — |
- 2026$22.2B-40.2%
- 2025$37.2B+228.3%
- 2024$11.3B+160.2%
- 2023$4.35B+77.0%
- 2022$2.46B-19.5%
- 2021$3.05B-6.0%
- 2020$3.25B+60.9%
- 2019$2.02B+100.2%
- 2018$1.01B-51.4%
- 2017$2.08B+153.5%
- 2016$819M-23.1%
- 2015$1.06B+59.6%
- 2014$667M+12.1%
- 2013$595M+234.9%
- 2012$178M+149.4%
- 2011$71.2M-14.8%
- 2010$83.6M-14.7%
- 2009$98M+71.6%
- 2008$57.1M-39.7%
- 2007$94.6M+12.8%
- 2006$83.9M-12.6%
- 2005$96M+11.5%
- 2004$86.1M-18.6%
- 2003$106M+626.7%
- 2002$14.5M-88.4%
- 2001$126M+97.6%
- 2000$63.5M—
Market Cap values are taken from Insmed's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Insmed (INSM)
According to Insmed's latest reported financial statements, the company's latest reported market cap is $35.2B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2026 reading of Insmed (INSM) market cap is $22.2B – plunged 40.2% year-over-year.
Through 2021–2026 (5 years), Insmed market cap delivered a +48.7% annualised rate; with mixed annual results across the window.
Between 2025 and 2026, Insmed market cap plunged 40.2%, falling from $37.2B to $22.2B.
2025 marks the peak market cap at $37.2B, with the historical low of $14.5M recorded in 2002.
Insmed Market Cap by Year
Insmed Market Cap 2026: $22.2B
In 2026, Insmed reported market cap of $22.2B, plunged 40.2% below 2025.
Insmed Market Cap 2025: $37.2B
Insmed market cap in 2025 was $37.2B, surged 228.3% from 2024. This figure represents the highest annual value in the available history.
Insmed Market Cap 2024: $11.3B
2024's market cap for Insmed came in at $11.3B, surged 160.2% from 2023.
Insmed Market Cap 2023: $4.35B
Insmed posted market cap of $4.35B in 2023, surged 77.0% from 2022.
Insmed Market Cap 2022: $2.46B
Insmed market cap in 2022 was $2.46B.
See more financial history for Insmed (INSM).
Sector peers by Market Cap
Healthcare peers of Insmed (INSM), ranked by their latest market cap
| $1.14T | |
| $640B | |
| $466B | |
| $382B | |
| $322B | |
| $229B | |
| $214B | |
| $209B |
- $1.14T
- $466B
- $322B
- $229B
- $209B
Frequently asked questions
Test yourself on INSM
Market Cap — 10 rounds, every one of them INSM against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Insmed (INSM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.